ReviewCureus2025
Livor Mortis and Forensic Dermatology: A Review of Death-Related Gravity-Dependent Lividity and Postmortem Hypostasis.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Early Postmortem Changes in NADH Fluorescence Lifetime Parameters in Rat Skeletal Muscle: Potential for Postmortem Interval Estimation.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Livor mortis is an early postmortem change; it is also referred to as dependent lividity or postmortem hypostasis. This is a narrative review; the PubMed search engine was used to obtain citations of relevant articles. The following terms, by themselves and in combination, were used to screen for appropriate published manuscripts that described the features of livor mortis: color, cutaneous, dermatology, fatal, forensic, hypostasis, lividity, livor, mortis, and postmortem. The articles obtained from those searches were reviewed, and the relevant references cited by the articles were evaluated. Lividity typically presents as small blanchable red-purple macules and patches on the dependent areas of the decedent; it is usually observed within two hours after the person has died; however, it can be noted as early as 20 minutes after death. After four to six hours, hypostasis becomes more readily apparent; the smaller lesions become confluent and occur in larger regions of the body. However, contact pallor is observed in the dependent areas affected by direct pressure; these sites do not become red-purple. Livor mortis is usually "fixed," and not blanchable, after eight to 12 hours. A bruise is the most common condition in the clinical differential diagnosis of lividity. The onset and duration until fixation of postmortem hypostasis are variable; lividity is also influenced not only by temperature but also by other factors. Livor mortis has at least three potential applications in forensic medicine. The first is that lividity, usually in combination with information from other postmortem changes, can be used to estimate the time since death; however, livor mortis is not reliable as an independent observation for establishing a range for the postmortem interval. The second is that livor mortis, when fixed, can be very helpful to establish that a decedent has been moved after death. The third is that the color of the lividity may possibly provide information regarding the cause of death; for example, carbon monoxide intoxication, hypothermia, or cyanide poisoning can be associated with cherry-red or pink lividity. New discoveries in medical technology have provided the ability to incorporate the use of spectrophotometric analysis of lividity to provide an objective assessment of postmortem hypostasis and correlate the information to more accurately estimate the postmortem interval.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.